# Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

> **NCT04189679** · — · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 62 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **OTHER:** Immune signature in serum associated to the metabolic signature
- **GENETIC:** Meta-genomic signature of intestinal flora

## Key facts

- **NCT ID:** NCT04189679
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-03
- **Primary completion:** 2023-01-27
- **Final completion:** 2023-01-27
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04189679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04189679, "Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04189679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*